FDA approves LILETTA (levonorgestrel-releasing intrauterine system) to prevent pregna

[News]

Actavis plc, a leading global specialty pharmaceutical company, and Medicines360, a nonprofit women's health pharmaceutical company, today announced the approval of LILETTA (levonorgestrel-releasing intrauterine system) by the U.S. Food and Drug Administration for use by women to prevent pregnancy for up to three years.

More... (http://www.news-medical.net/news/20150227/FDA-approves-LILETTA-(levonorgestrel-releasing-intrauterine-system)-to-prevent-pregnancy.aspx)